| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |